Table 2 Sustained virological response (SVR) rate stratified by IL28B genotypes in Hungarian HCV patients
Treated | SVR | ||
|---|---|---|---|
IL28B genotype | n | Number of patients | Percentage |
CC | 116 | 68 | 58.6% |
CT | 228 | 93 | 40.8% |
TT | 76 | 34 | 44. 7% |
T allele (non-CC) | 304 | 127 | 41.8% |
Treated | SVR | ||
|---|---|---|---|
IL28B genotype | n | Number of patients | Percentage |
CC | 116 | 68 | 58.6% |
CT | 228 | 93 | 40.8% |
TT | 76 | 34 | 44. 7% |
T allele (non-CC) | 304 | 127 | 41.8% |